Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141567 · ClinicalTrials.gov registry record
LYmphangiogenesis FacTors in Heart Failure States
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 100
- Enrollment target
NCT03141567 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 100 participants.
The verdict
NCT03141567 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Heart failure often causes fluid to accumulate in the body, leading to congestion and swelling. However, some people who have had heart failure for a long time seem to have very little congestion or swelling, even when the heart failure is poorly treated. The investigators think that this is because lymphatic vessels are able to grow and remove fluid to prevent congestion. The investigators do not know how lymphatic vessels grow. This study will investigate the blood levels of various proteins to try to figure out how the lymph vessels of people with long-standing heart failure might grow.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2023-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03141567
The ClinicalTrials.gov registry entry for NCT03141567 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03141567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03141567 about?
NCT03141567 is a clinical study titled "LYmphangiogenesis FacTors in Heart Failure States". Heart failure often causes fluid to accumulate in the body, leading to congestion and swelling. However, some people who have had heart failure for a long time seem to have very little congestion or swelling, even when the heart failure is poorly treated. The investigators think that this is because...
What is the current status of trial NCT03141567?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-05-18. Estimated completion is 2023-01-24.
Who is sponsoring clinical trial NCT03141567?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.